%PDF-1.4
%
84 0 obj
<>>>
endobj
86 0 obj
<>/Font<>>>/Fields[]>>
endobj
85 0 obj
<>
endobj
62 0 obj
<>stream
Adobe PDF Library 15.0
False
2019-01-14T10:18:38+08:00
2019-06-17T09:33:34-07:00
2019-06-17T09:33:34-07:00
Adobe InDesign CC 2017 (Windows)
uuid:082d65dc-1dd2-11b2-0a00-af0058c49dff
xmp.did:f4fd3488-9b3f-9d45-a5a3-8a4b2d55f952
xmp.id:acfb18a2-43bd-bb4a-be5d-fee3d6c809d1
proof:pdf
xmp.iid:b2d68162-1d0b-384a-9b89-abc7fa1e3e87
xmp.did:3c1a44db-b4cf-7e40-805f-12478d22c8a0
xmp.did:f4fd3488-9b3f-9d45-a5a3-8a4b2d55f952
default
converted
from application/x-indesign to application/pdf
Adobe InDesign CC 2017 (Windows)
/
2019-01-14T10:18:38+08:00
application/pdf
Science Journals — AAAS
endstream
endobj
81 0 obj
<>
endobj
14 0 obj
<>
endobj
83 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 82 0 R/TrimBox[0 0 594 756]/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/Thumb 2 0 R/TrimBox[0 0 594 756]/Type/Page>>
endobj
16 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/Thumb 17 0 R/TrimBox[0 0 594 756]/Type/Page>>
endobj
22 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/Rotate 0/Thumb 23 0 R/TrimBox[0 0 594 756]/Type/Page>>
endobj
29 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>/XObject<>>>/Rotate 0/Thumb 30 0 R/TrimBox[0 0 594 756]/Type/Page>>
endobj
45 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 46 0 R/TrimBox[0 0 594 756]/Type/Page>>
endobj
59 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 60 0 R/TrimBox[0 0 594 756]/Type/Page>>
endobj
143 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
165 0 obj
[170 0 R 171 0 R 172 0 R 173 0 R 174 0 R 175 0 R 176 0 R 177 0 R 178 0 R 179 0 R]
endobj
166 0 obj
<>stream
q
304.25 0 0 21.75 84 662.25 cm
/Im0 Do
Q
BT
/T1_0 1 Tf
10 0 0 10 84 622 Tm
(Tuberculosis following PD-1 blockade for cancer immunotherapy)Tj
ET
BT
/T1_1 1 Tf
8 0 0 8 84 592.99994 Tm
(Paul T. Nghiem and Elad Sharon)Tj
0 1 TD
(Ashkin, Jonathan H. Cheng, Lisa M. Lundgren, Vanessa N. Raabe, Colleen S\
. Kraft, Jorge J. Nieva, Martin A. Cheever, )Tj
0 1.00001 TD
(Daniel L. Barber, Shunsuke Sakai, Ragini R. Kudchadkar, Steven P. Fling,\
Tracey A. Day, Julie A. Vergara, David)Tj
ET
BT
/T1_1 1 Tf
8 0 0 8 84 546.99997 Tm
(DOI: 10.1126/scitranslmed.aat2702)Tj
8.05798 1 Td
(, eaat2702.)Tj
/T1_0 1 Tf
-1.112 0 Td
(11)Tj
/T1_2 1 Tf
-6.94598 0 Td
(Sci Transl Med )Tj
ET
BT
/T1_1 1 Tf
8 0 0 8 104 466.99982 Tm
(instead worsen the disease.)Tj
0 1 TD
(deficiency exacerbated disease. This report indicates that PD-1 blockade\
for treating tuberculosis in humans may)Tj
0 1.00001 TD
(presentation of TB. These results are in line with previous work in mous\
e TB models, which showed that PD-1 )Tj
42.46294 1 Td
(1 cells before)Tj
-0.33333 Ts -0.722 0 Td
(H)Tj
0 Ts -41.74094 0 Td
(longitudinal samples available from one of the patients revealed the pre\
sence of TB-specific T)Tj
8.22498 1.00001 Td
( studied two patients with cancer who developed active TB during PD-1 bl\
ockade. Analysis of)Tj
/T1_2 1 Tf
-2.168 0 Td
(et al.)Tj
/T1_1 1 Tf
-6.05698 0 Td
(\(TB\). Barber )Tj
3.125 1 Td
(Scientists are interested in leveraging PD-1 blockade for diseases other\
than cancer, such as tuberculosis)Tj
/T1_0 1 Tf
-3.125 1 Td
(Preaching caution with PD-1 blockade for TB)Tj
ET
BT
/T1_0 1 Tf
6 0 0 6 91 421 Tm
(ARTICLE TOOLS)Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
8 0 0 8 199 419 Tm
(http://stm.sciencemag.org/content/11/475/eaat2702)Tj
ET
BT
0 g
/T1_0 1 Tf
6 0 0 6 91 378.99997 Tm
(MATERIALS)Tj
T*
(SUPPLEMENTARY )Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
8 0 0 8 199 383 Tm
(http://stm.sciencemag.org/content/suppl/2019/01/14/11.475.eaat2702.DC1)Tj
ET
BT
0 g
/T1_0 1 Tf
6 0 0 6 91 336.99997 Tm
(CONTENT)Tj
T*
(RELATED )Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
8 0 0 8 199 316.99991 Tm
(http://stm.sciencemag.org/content/scitransmed/10/450/eaar3342.full)Tj
0 1 TD
(http://stm.sciencemag.org/content/scitransmed/10/454/eaar4470.full)Tj
0 1.00001 TD
(http://stm.sciencemag.org/content/scitransmed/10/430/eaam6310.full)Tj
0 1 TD
(http://stm.sciencemag.org/content/scitransmed/10/459/eaat7807.full)Tj
ET
BT
0 g
/T1_0 1 Tf
6 0 0 6 91 301 Tm
(REFERENCES)Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
8 0 0 8 199 290.99997 Tm
(http://stm.sciencemag.org/content/11/475/eaat2702#BIBL)Tj
0 g
T*
(This article cites 31 articles, 8 of which you can access for free)Tj
ET
BT
/T1_0 1 Tf
6 0 0 6 91 265 Tm
(PERMISSIONS)Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
8 0 0 8 199 263 Tm
(http://www.sciencemag.org/help/reprints-and-permissions)Tj
ET
BT
/T1_1 1 Tf
8 0 0 8 205.38391 128 Tm
(Terms of Service)Tj
0 g
-15.17299 0 Td
(Use of this article is subject to the )Tj
ET
84 114 m
510 114 l
0 0 m
S
BT
ET
BT
/T1_1 1 Tf
8 0 0 8 211.59985 77.99991 Tm
( is a registered trademark of AAAS.)Tj
/T1_2 1 Tf
-13.83798 0 Td
(Science Translational Medicine)Tj
/T1_1 1 Tf
-2.112 0 Td
(title )Tj
T*
(licensee American Association for the Advancement of Science. No claim t\
o original U.S. Government Works. The)Tj
0 1.00001 TD
(Science, 1200 New York Avenue NW, Washington, DC 20005. 2017 \251 The Au\
thors, some rights reserved; exclusive )Tj
14.11598 1 Td
(\(ISSN 1946-6242\) is published by the American Association for the Adva\
ncement of)Tj
/T1_2 1 Tf
-14.11598 0 Td
(Science Translational Medicine )Tj
ET
BT
/T1_1 1 Tf
0 -8 8 0 578 346.89215 Tm
( by guest on June 17, 2019)Tj
0 0 1 rg
-11.72697 0 Td
(http://stm.sciencemag.org/)Tj
0 g
-8.11399 0 Td
(Downloaded from )Tj
ET
endstream
endobj
169 0 obj
<>/Filter/FlateDecode/Height 87/Length 66928/Name/X/Subtype/Image/Type/XObject/Width 1217>>stream
HT{gf
(Kbc`$H1)1cZ=&Vi1IGi4ԪTL@9DARPy.(1硫3̽f XU]ksM&D3㘀L}E